Can a YC 'War Chest' Fuel Toronto's Deep-Tech Ambitions?

Toronto has no shortage of brilliance, but as Zaky Hassan puts it, the city is a "crazy place for talent" filled with grad students and postdocs capable of immense work. The question is whether that talent can actually build a global bio-company here. Enter Molagri, a startup as first reported on by BetaKit.

Founded by Zaky Hassan and Min Jin—both University of Toronto PhD candidates who specialized in common cold coronaviruses—Molagri is attempting a high-science moonshot. According to reporting from BetaKit, the startup is leveraging AI-driven advancements in protein design to create pesticides that evolve alongside the pests they target. By building on a non-infectious insect virus, the company can engineer proteins to "blacklist" and "whitelist" targets, allowing them to tweak formulations to stay ahead of pest resistance. Hassan compares the model to a flu vaccine: the farmer shouldn't have to worry about the specific strain; the solution should already be handled in the back end.

***

**Opinion:** In a city often obsessed with the predictable margins of SaaS, Molagri is exactly the kind of ambitious, deep-tech play Toronto needs to anchor its ecosystem. However, the path to getting here reveals a sobering reality about our local venture landscape.

***

As BetaKit reports, Hassan and Jin initially sought Canadian investors to fund their vision but were unsuccessful. Hassan attributed this failure to the risk aversion of investors within Canada. To get off the ground, the duo secured $1 million USD ($1.4 million CAD) in pre-seed backing from the US-based deeptech VC Julian Capital and Y Combinator.

This capital allowed the team to secure lab space at the MaRS Discovery District and hire their first scientist. Now, as they prepare for Y Combinator’s Demo Day on Sept. 10, Hassan tells BetaKit that the goal is to return to Toronto with a "war chest" to hire more scientists and develop products farmers love.

While the long-term goal is to make Molagri a global producer, the immediate "wedge product" is focused on tree fruits and tree nuts—crops with an "acute insecticide need"—which means much of their early focus will be on California.

Scaling a bio-company requires more than just a few million dollars; it requires a sustained appetite for high-risk, high-reward science. If Molagri succeeds in building its headquarters in Toronto, it will be a victory for the local ecosystem, but it will also serve as a reminder that our best founders often have to find their first believers in Silicon Valley before they can bring that momentum home.